Charles Dudognon

521 citations
10 papers · 409 indexed · h-index 9
Topics
Telomeres, Telomerase, and Senescence (6 papers)Retinoids in leukemia and cellular processes (3 papers)Acute Myeloid Leukemia Research (2 papers)

In The Last Decade

Charles Dudognon

10 papers receiving 402 citations

Peers

Charles Dudognon
Comparison fields: 5 of 57
  • Molecular Biology 303
  • Physiology 171
  • Oncology 60
  • Biotechnology 43
  • Immunology 41
Replace M Yamada with:
M Yamada Japan
Bilal Unal Norway
Jennifer V. Grobelny United States
Frauke Goeman Italy
Landon G. Piluso United States
Hongyu Deng China
Junko Horiguchi‐Yamada Japan
Claudia Lucotti Italy
Eunkyong Ko South Korea
Jessica Ekedahl Sweden
Charles Dudognon relative to M Yamada Japan M Yamada's profile →
Citations per field
00.5×
M Yamada · 1×
Citations per year

Countries citing papers authored by Charles Dudognon

Since Specialization
Citations

This map shows the geographic impact of Charles Dudognon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charles Dudognon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charles Dudognon more than expected).

Fields of papers citing papers by Charles Dudognon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Charles Dudognon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charles Dudognon. The network helps show where Charles Dudognon may publish in the future.

Co-authorship network of co-authors of Charles Dudognon

This figure shows the co-authorship network connecting the top 25 collaborators of Charles Dudognon. A scholar is included among the top collaborators of Charles Dudognon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Charles Dudognon. Charles Dudognon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
#WorkIndexed citations
1 45
2 39
3 13
4 58
5 98
6 28
7
[Cell death signalling: recent advances and therapeutic application].
2
8 66
9 32
10 28

About Charles Dudognon

Charles Dudognon is a scholar working on Biochemistry, Physiology and Hematology, having authored 10 papers that have together received 409 indexed citations. Recurring topics across this work include Telomeres, Telomerase, and Senescence (6 papers), Retinoids in leukemia and cellular processes (3 papers) and Acute Myeloid Leukemia Research (2 papers). The work is most often cited by research in Physiology (171 citations), Biotechnology (43 citations) and Aging (8 citations). Charles Dudognon has collaborated with scholars based in France, Hungary and United States. Frequent co-authors include E. Segal, Josette Hillion, Frédéric Pendino, Michel Lanotte, Susan Smith, János Aradi, Mi Kyung Kim, Michele Lanotte, Anne Saumet and Guoqiang Chen. Their work appears in journals such as Journal of Biological Chemistry, Molecular and Cellular Biology and Oncogene.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026